O'Brien Greene & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $264K | Buy |
|
|||||
|
2025
Q1 | $346K | Sell |
|
|||||
|
2024
Q4 | $321K | Sell |
|
|||||
|
2024
Q3 | $313K | Sell |
|
|||||
|
2024
Q2 | $262K | Buy |
|
|||||
|
2024
Q1 | $331K | Hold |
|
|||||
|
2023
Q4 | $313K | Sell |
|
|||||
|
2023
Q3 | $372K | Sell |
|
|||||
|
2023
Q2 | $420K | Sell |
|
|||||
|
2023
Q1 | $477K | Hold |
|
|||||
|
2022
Q4 | $495K | Sell |
|
|||||
|
2022
Q3 | $1.62M | Buy |
|
|||||
|
2022
Q2 | $583K | Buy |
|
|||||
|
2022
Q1 | $540K | Sell |
|
|||||
|
2021
Q4 | $463K | Sell |
|
|||||
|
2021
Q3 | $450K | Hold |
|
|||||
|
2021
Q2 | $509K | Hold |
|
|||||
|
2021
Q1 | $480K | Buy |
|
|||||
|
2020
Q4 | $398K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $205K | Buy |
|